User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

6233

Interactions with Platform & by Email *

INTERACTIONS

997

Unique # Participated *

PARTICIPANTS

187

Responses Validated *

VALIDATIONS

40

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   A Quick Primer.....II-1
Synthetic Biology: Prediction Becoming Reality.....II-1
2$200
   Current and Future Analysis.....II-3
Analysis by Region.....II-3
1$100
   Analysis by Product Segment.....II-4
Analysis by End-Use Market.....II-4
1$100
   Key Growth Drivers and Major Concerns.....II-5
Growth Drivers.....II-5
Major Concerns.....II-5
1$100
   Future Outlook.....II-61$100
   Synthetic Biology – An Emerging Discipline in Need of Promotion.....II-7
Contribution of Synthetic Biology to Biotech.....II-7
Craig Venter’s Synthetic Life: Momentous Achievement in Synthetic Biology
  Field.....II-7
1$100
   Gibson Assembly®: Building Toolset for Synthetic Biology.....II-8
Gen9’s BioFab: Major Breakthrough in Synthetic Biology.....II-8
1$100
   Key Developments in the Synthetic Biology Field: A Synopsis.....II-92$200
   Synthetic Biology Products with Commercial Potential in the Future by End
  Market.....II-11
1$100
   Competitive Landscape.....II-12
Competition in Synthetic Biology Market.....II-12
1$100
   Intrexon: Leader in Synthetic Biology Field.....II-13
Key Factors Contributing to Intrexon’s Success in Synthetic Biology Field.....II-13
Proprietary Suite of Innovative Technologies.....II-13
1$100
   Unique ECC-based Business Model.....II-141$100
   A Synopsis of Intrexon’s ECC Agreements: 2011-2013.....II-151$100
   Is Synthetic Biology a Bane or Boon?.....II-16
Synthetic Biology Exhibits Plateau in Awareness.....II-16
Synthetic Biology Research Gathers Momentum.....II-16
1$100
   US and Europe - Propelling Research in the Field of Synthetic Biology.....II-17
Table 1: Number of Entities Focused on Synthetic Biology Research Globally: 2009 & 2013 (includes corresponding Graph/Chart).....II-17
1$350
   Table 2: Synthetic Biology and their Potential Areas of Applications Being Researched by Biological Systems Manufacturers/Designers (includes corresponding Graph/Chart).....II-181$350
   Table 3: Number of Biological Systems Manufacturers/Designers Focused on Specialty/Fine Chemical Applications (includes corresponding Graph/Chart).....II-191$350
   Table 4: Number of Patent Filings Related to Synthetic Biology: 2003-2013 (includes corresponding Graph/Chart).....II-201$350
   Table 5: Leading Filers of Patent Applications Related to Synthetic Biology: 2003-2013 (includes corresponding Graph/Chart).....II-211$350
   Synthetic Biology Mired by Challenges in Developing Countries.....II-22
Synthetic Biology Bringing a Paradigm Shift in the Field of Biological
  Research.....II-22
1$100
   DNA Sequencing Technique Propelling Growth for Synthetic Biology.....II-23
Plummeting Cost of DNA Sequencing Bolsters Market Growth.....II-23
1$100
   Table 6: Cost per Genome Sequencing: 2001-2014.....II-24
Systems Biology Leading to Advancements in Synthetic Biology.....II-24
Synthetic Biology based Microbial Factories for Production of Poppies.....II-24
1$350
   Food and Other Basic Needs’ Scarcity to Fuel Synthetic Biology Market.....II-25
Food, Water, and Energy Statistics.....II-25
1$100
   Table 7: Top 20 Countries Worldwide in Terms of Population in Million (2014) (includes corresponding Graph/Chart).....II-26
Will Synthetic Biology Mitigate Food Security Concerns?.....II-26
1$350
   Growing Demand for GM Crops Opens Up Growth Avenues.....II-271$100
   Synthetic Biology-based Ingredients Gain Traction.....II-28
Role of Synthetic Biology in Producing Plants with Desirable Characteristics.....II-28
1$100
   Do-It-Yourself Biology (DIYBio): A Growing Phenomenon.....II-291$100
   Synthetic Biology Ingredients in Consumer Products - Laden with Concerns.....II-30
Synthetic Biology Gaining Prominence in Biomedical Applications.....II-30
1$100
   Research Efforts in Full Swing to Treat Life-Threatening Diseases using Synthetic
  Biology.....II-31
1$100
   Synthetic Biology Therapeutics to Address Antibiotic-Resistance Crisis.....II-321$100
   Pipeline Perspective of Synthetic Biology Therapeutics (Synthetic Biologics and
  Intrexon Collaboration).....II-33
Synthetic Biology for Wildlife Conservation Laden with Risks.....II-33
Synthetic Biology Enabling Creation of Advanced Biosensing Systems.....II-33
1$100
   Synthetic Biology Gains Significance in Production of Bio-Based Chemicals and
  Biofuels.....II-34
1$100
   Contribution of Synthetic Biology to Renewable Chemicals.....II-352$200
   Synthetic Biology for Energy Supply: Potential Threat to Biodiversity.....II-37
SynBio Products and Ingredients Face Opposition from Several Organizations.....II-37
1$100
   Lack of Regulatory Framework - A Major Concern.....II-381$100
   Biologists Implants Artificial Chromosome in Yeast to Create Artificial Life.....II-39
Synthetic Genes to Open New World of Drug Development.....II-39
1$100
   Researchers Announce Production of Peptoid Nanosheets.....II-40
Synthetic Biology in Repelling Viruses.....II-40
Synthetic Biology in Engineered Food.....II-40
1$100
   Synthetic Biology to Address Issues Related to Algal Blooms.....II-41
Synthetic Biology Holds Potential for Testing Water Purity.....II-41
Mars – A Home Away from Home Courtesy Synthetic Biology.....II-41
Predictable Biological Systems - No More a Myth.....II-41
Researchers at JCVI Make Novel Advances in Synthetic Genomics.....II-41
1$100
   Synthetic Biology Tools Can Detect Listeria Contamination in Food Products.....II-42
Synthetic Biology Accelerates Flu Vaccine Production.....II-42
1$100
   Bioengineers at Duke University Develops Novel System for Reproducing Natural Complex
  Gene Regulation.....II-43
TALE: A Viable Technology for Synthetic Protein Development.....II-43
Can Synthetic Biology Fuel Cars or Household Power Supplies Using Naturally-Existing
  Fatty Acids?.....II-43
1$100
   Researchers Engineered Synthetic Compound to Defend Iron Deficiency.....II-44
Cellular Circuit Designing Made Possible through Biological Genes.....II-44
1$100
   Meshing Inputs/Outputs Offer Layered Circuits.....II-45
Cambrian Genomics Pioneers DNA Laser Printer.....II-45
Researchers Develop Novel Technique that Speeds the Process for Developing New
  Biological Parts.....II-45
1$100
   Researchers Develop Novel Biological Device that Mimics Transistor-Like
  Properties.....II-46
1$100
   Introduction.....II-47
Historical Background.....II-47
Synthetic Biology Vis-à-vis Genetic Engineering - A Comparison.....II-47
1$100
   Scope of Synthetic Biology in Various Fields.....II-48
Engineering.....II-48
Chemistry.....II-48
Major Enabling Technologies.....II-48
Sequencing.....II-48
1$100
   Fabrication.....II-49
Modeling.....II-49
Measurement.....II-49
Synthetic Biology Market – By Product.....II-49
Core Products/Biologic Components.....II-49
Synthetic Genes.....II-49
1$100
   Synthetic Cells.....II-50
Chassis Organisms.....II-50
1$100
   Escherichia coli.....II-51
Bacillus subtilis.....II-51
Yeast.....II-51
Mycoplasma.....II-51
Acinetobacter.....II-51
Mycoplasma genitalium.....II-51
XNA (Xeno Nucleic Acid).....II-51
1$100
   Enabling Products.....II-52
DNA Synthesis.....II-52
Oligonucleotide Synthesis.....II-52
1$100
   Market Potential.....II-53
Pharmaceutical.....II-53
Industrial.....II-53
Agriculture.....II-53
Life Sciences Research.....II-53
Renewable Energy.....II-53
1$100
   Synthetic Biology Applications/Products with Highest Potential for Commercialization
  by 2030.....II-54
Potential Uses.....II-54
1$100
   Biomedicine.....II-55
Intricate Molecular Devices Utilized for Tissue Regeneration/Repair.....II-55
Smart Drugs.....II-55
Biological Delivery Systems.....II-55
Vectors for Therapy.....II-55
Personalized Medicine.....II-55
Cells with Novel Properties for Betterment of Human Health.....II-55
1$100
   In Vivo Synthesis of Small-Molecule Pharmaceuticals.....II-56
Intricate Natural Products.....II-56
Expansion of Chemistry of Life.....II-56
Expanding Genetic Alphabet.....II-56
Nucleic Acids.....II-56
1$100
   Proteins.....II-57
New Imaging and Targeting Methods.....II-57
Chemical Industry Sustainability.....II-57
Eco-friendly Production of Chemicals.....II-57
Energy and Environment.....II-57
Bioremediation.....II-57
Energy Production.....II-57
Biomaterials and Smart Materials Production.....II-57
1$100
   Synthesis.....II-58
Organization.....II-58
Socio-Economic Concerns and Risks of Synthetic Biology.....II-58
Production of Bio-Weapons.....II-58
Accidental Release.....II-58
Return on Investment.....II-58
Dissonance with Other Disciplines.....II-58
1$100
   Continuous Evolution.....II-59
Curtailed Understanding.....II-59
Unpredictable Ecosystem Effects.....II-59
Unexpected Transfer of Genes.....II-59
Aggravating Problems.....II-59
Industry Associations.....II-59
Synthetic Biology Industry Association (SynBIA).....II-59
1$100
   Industry Association of Synthetic Biology (IASB).....II-601$100
   Synthetic Biologics Obtains Orphan Drug Designation for SYN-005 mAb.....II-61
Agilent Technologies Introduces SureGuide Kits.....II-61
Agilent Technologies Rolls Out ClearSeq AML Next-Generation Sequencing Cancer
  Research Panels.....II-61
Gen9 Rolls Out Variant Libraries.....II-61
Gen9 Introduces GeneByte Plus™ DNA Constructs.....II-61
Agilent Technologies Introduces SureSelect Clinical Research Exome.....II-61
1$100
   Agilent Technologies Launches QuikChange HT Protein Engineering Synthetic Biology
  System.....II-62
GenScript Introduces GenEZ™ Next-Generation Molecular Cloning Service.....II-62
DNA2.0 Releases CRISPR/Cas9 Tools for Genome Editing and Engineering.....II-62
GenScript Unveils GenPlus™ Next-Generation Gene Synthesis Technology.....II-62
Life Technologies Introduces new GeneArt® Algae Protein Expression Kits.....II-62
Life Technologies Unveils Vector NTI® Express Designer Bioinformatics Software
  Platform.....II-62
Gen9 Introduces GeneBytes™ DNA Constructs.....II-62
1$100
   New England Biolabs and Synthetic Genomics Launches Gibson Assembly Cloning Kit and
  NEBuilder™ Primer Design Tool.....II-63
GenScript Introduces Gene-Brick™ Gene Synthesis Service.....II-63
1$100
   Genome Compiler Enters into Collaborative Agreement with DNA2.0.....II-64
Eurofins Genomics Enters into Co-operation Agreement with Igenbio.....II-64
Bacterial Robotics Signs Strategic Agreement with Bacmine.....II-64
Intrexon and Histogenics Enter into Exclusive Channel Collaboration for Cartilage
  Repair Therapies.....II-64
Intrexon and Amneal Pharmaceuticals Announce Second Exclusive Channel Collaboration
  for a Target API.....II-64
Synthetic Biologics and FUJIFILM Diosynth Biotechnologies Announces Positive Phase I
  Outcomes of API Manufacturing of SYN-004.....II-64
1$100
   Evolva Holding Acquires Prosarix.....II-65
Igenbio Collaborates with Genome Compiler.....II-65
Pareto Biotechnologies Enters into Technology Partnership with DNA2.0.....II-65
Roche Enters into Research Agreement with Stratos Genomics.....II-65
Cellectis Enters into Agreement with Thermo Fisher Scientific.....II-65
Roche Acquires Genia Technologies.....II-65
Synthorx, a New Synthetic Biotechnology Company Launches.....II-65
Synthetic Genomics Enters into Long-Term R&D Agreement with Lung Biotechnology.....II-65
1$100
   OriGene Introduces Genome-wide Gene-knockout Kits.....II-66
Intrexon Concludes Acquisition of Medistem.....II-66
Amyris Enters into Collaborative R&D Agreement with BASF.....II-66
MIT SBC Collaborates with Pfizer.....II-66
Tauriga Sciences Acquires Pilus Energy LLC.....II-66
OvaScience and Intrexon Enter into Agreement.....II-66
Sanofi Commences Large-Scale Production of Semi-Synthetic Artemisinin.....II-66
1$100
   EVOLVA and IFF Enter into Pre-Manufacturing Phase for Natural Vanillin.....II-67
Synthetic Genomics Enters into Research Agreement with ExxonMobil.....II-67
Amyris Signs Long Term Agreement with International Flavors & Fragrances.....II-67
SGI-DNA and IDT Announce Expanded Collaboration.....II-67
College of Engineering Establishes BU Center of Synthetic Biology.....II-67
Gen9 Enters into Partnership with Agilent Technologies.....II-67
AquaBounty Technologies Enters into Exclusive Channel Collaboration with
  Intrexon.....II-67
Synthetic Biologics Collaborates with Intrexon for Infectious Disease
  Therapies.....II-67
1$100
   DuPont Collaborates with OligoCo.....II-68
DNA2.0 Collaborates with Newcastle University.....II-68
Amyris Secures Contract from the US DARPA.....II-68
Pfenex Collaborates with DNA2.0.....II-68
Synthetic Genomics Inks Agreement with New England Biolabs.....II-68
Amyris Commences Production of Biofene in Brazil.....II-68
1$100
   Players Focused on Synthetic Biology Applications.....II-69
Amyris, Inc. (US).....II-69
1$100
   BP PLC. (UK).....II-70
Chromatin Inc. (US).....II-70
1$100
   Evolva SA (Switzerland).....II-71
Gevo, Inc. (US).....II-71
1$100
   Joule Unlimited, Inc. (US).....II-72
Metabolix (US).....II-72
MorphoSys AG (Germany).....II-72
1$100
   Sapphire Energy, Inc. (US).....II-73
Solazyme, Inc. (US).....II-73
Synthetic Biologics, Inc. (US).....II-73
1$100
   Synthetic Genomics, Inc. (US).....II-74
Players Focused on Gene Synthesis and Tools.....II-74
454 Life Sciences (US).....II-74
1$100
   Agilent Technologies Inc. (US).....II-75
ATG Biosynthetics GmbH (Germany).....II-75
1$100
   DNA2.0 (US).....II-76
Epoch Life Science, Inc. (US).....II-76
1$100
   Gen9, Inc. (US).....II-77
GenScript USA, Inc. (US).....II-77
1$100
   Gingko Bioworks, Inc. (US).....II-78
Intrexon Corporation (US).....II-78
1$100
   LC Sciences LLC (US).....II-79
Life Technologies Corp. (US).....II-79
1$100
   OPXBIO, Inc. (US).....II-80
OriGene Technologies, Inc. (US).....II-80
1$100
   Sangamo BioSciences, Inc. (US).....II-81
Verdezyne, Inc. (US).....II-81
1$100
   Table 8: World Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-821$350
   Table 9: World Historic Review for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-831$350
   Table 10: World 14-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-841$350
   Table 11: World Recent Past, Current & Future Analysis for Synthetic Biology by Product Segment - Enabled Products and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-851$350
   Table 12: World Historic Review for Synthetic Biology by Product Segment - Enabled Products and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-861$350
   Table 13: World 14-Year Perspective for Synthetic Biology by Product Segment - Percentage Breakdown of Dollar Sales for Enabled Products and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-871$350
   Table 14: World Recent Past, Current & Future Analysis for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-881$350
   Table 15: World Historic Review for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-891$350
   Table 16: World 14-Year Perspective for Synthetic Biology by End-Use Sector - Percentage Breakdown of Dollar Sales for Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-901$350
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
Research in the US.....III-1
Table 17: Number of Entities Focused on Synthetic Biology Research in the US (2009 & 2013) (includes corresponding Graph/Chart).....III-1
1$200
   International Genetically Engineered Machine (IGEM) – A Platform for
  Innovations.....III-2
Product Launches.....III-2
2$150
   Strategic Corporate Developments.....III-45$375
   Key Players.....III-910$750
   B. Market Analytics.....III-19
Table 18: US Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-19
1$200
   Table 19: US Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-201$200
   Market Analysis.....III-21
Table 20: Canadian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-21
1$200
   Table 21: Canadian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-221$200
   Market Analysis.....III-23
Table 22: Japanese Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-23
1$200
   Table 23: Japanese Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-241$200
   A. Market Analysis.....III-25
Current & Future Analysis.....III-25
Research in Europe.....III-25
1$75
   Table 24: Number of Entities Focused on Synthetic Biology Research in Europe (2009 & 2013) (includes corresponding Graph/Chart).....III-261$200
   Table 25: Number of Entities Focused on Synthetic Biology Research by Area of Interest: 2013 (includes corresponding Graph/Chart).....III-271$200
   B. Market Analytics.....III-28
Table 26: European Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-28
1$200
   Table 27: European Historic Review for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-291$200
   Table 28: European 14-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-301$200
   A. Market Analysis.....III-31
Current & Future Analysis.....III-31
Strategic Corporate Development.....III-31
1$75
   B. Market Analytics.....III-32
Table 29: French Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-32
1$200
   Table 30: French Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-331$200
   A. Market Analysis.....III-34
Current & Future Analysis.....III-34
Key Players.....III-34
1$75
   B. Market Analytics.....III-35
Table 31: German Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-35
1$200
   Table 32: German Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-361$200
   Market Analysis.....III-37
Table 33: Italian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-37
1$200
   Table 34: Italian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-381$200
   A. Market Analysis.....III-39
Current & Future Analysis.....III-39
Market Overview.....III-39
UK Government Awards Over £6 Million Grant For Synthetic Biology.....III-39
1$75
   Uk Government Funding For Synthetic Biology: 2013.....III-40
Synbicite Centre to Spearhead UK Research In Synthetic Biology.....III-40
UK Sets Up New Synthetic Biology Research Centers.....III-40
Synthetic Biology Research Centre Nottingham (Sbrc Nottingham).....III-40
1$75
   Bristol Centre for Synthetic Biology (Brissynbio).....III-41
Openplant Synthetic Biology Research Centre.....III-41
University of Edinburgh inks Agreement with BGI to Develop Artificial Yeast
  Genome.....III-41
Strategic Corporate Development.....III-41
1$75
   BP Plc. - A Key Player.....III-421$75
   B. Market Analytics.....III-43
Table 35: UK Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-43
1$200
   Table 36: UK Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-441$200
   A. Market Analysis.....III-45
Current & Future Analysis.....III-45
Strategic Corporate Development.....III-45
1$75
   B. Market Analytics.....III-46
Table 37: Spanish Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-46
1$200
   Table 38: Spanish Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-471$200
   A. Market Analysis.....III-48
Current & Future Analysis.....III-48
Evolva Sa (Switzerland) – A Major Player.....III-48
1$75
   B. Market Analytics.....III-49
Table 39: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-49
1$200
   Table 40: Rest of Europe Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-501$200
   A. Market Analysis.....III-51
Current & Future Analysis.....III-51
Table 41: Number of Entities Focused on Synthetic Biology Research in Asia and Oceania in 2013 (includes corresponding Graph/Chart).....III-51
1$200
   B. Market Analytics.....III-52
Table 42: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-52
1$200
   Table 43: Asia-Pacific Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-531$200
   A. Market Analysis.....III-54
Current & Future Analysis.....III-54
Strategic Corporate Development.....III-54
1$75
   B. Market Analytics.....III-55
Table 44: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-55
1$200
   Table 45: Rest of World Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-561$200
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com